Vitamin D as an adjuvant in melanoma therapy.

about

Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo models On the role of classical and novel forms of vitamin D in melanoma progression and management.Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.

P2860

Q37706071-2318EC0B-5A94-4756-B454-B2B1EC33355A Q38662850-2C6F40ED-4A39-4997-BEAB-C03E52E4B112 Q48218051-EAD3B71E-7F7C-42A4-AD4D-2A5D087515CB

P2860

Vitamin D as an adjuvant in melanoma therapy.

Item

http://www.wikidata.org/entity/Q41548479

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Vitamin D as an adjuvant in melanoma therapy.

@en

type

Item

label

Vitamin D as an adjuvant in melanoma therapy.

@en

prefLabel

Vitamin D as an adjuvant in melanoma therapy.

@en

P1476

Vitamin D as an adjuvant in melanoma therapy.

@en

P2093

Andrzej T Slominski

http://www.w3.org/2001/XMLSchema#string

Anna Brozyna

http://www.w3.org/2001/XMLSchema#string

Robert C Tuckey

http://www.w3.org/2001/XMLSchema#string

Wojciech Jozwicki

http://www.w3.org/2001/XMLSchema#string

P2860

New vitamin D analogs as potential therapeutics in melanoma

Vitamin D deficiency

Decreased VDR expression in cutaneous melanomas as marker of tumor progression: new data and analyses

Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma.

RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D.

Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.

Protective role of vitamin D signaling in skin cancer formation.

20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells.

Expression of vitamin D receptor decreases during progression of pigmented skin lesions.

25-Hydroxyvitamin D2 /D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort.

P304

1-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2217/MMT.14.36

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276385204

http://www.w3.org/2001/XMLSchema#string

P698

26052430

http://www.w3.org/2001/XMLSchema#string

P921

vitamin D

P932

4452022

http://www.w3.org/2001/XMLSchema#string

Vitamin D as an adjuvant in melanoma therapy.

about

P2860

P2860

Vitamin D as an adjuvant in melanoma therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932